In the BioHarmony Drug Report Database
Dobutamine
Dobutamine, Dobutrex (dobutamine) is a small molecule pharmaceutical. Dobutamine was first approved as Dobutamine on 1982-01-01. It is used to treat low cardiac output in the USA. The pharmaceutical is active against beta-1 adrenergic receptor.
Trade Name
|
Dobutamine, Dobutrex |
|---|---|
Common Name
|
dobutamine |
ChEMBL ID
|
CHEMBL926 |
Indication
|
low cardiac output |
Drug Class
|
Β1-agonist |
Image (chem structure or protein)